Tapewire

Nasdaq · USD

TRAW

Traws Pharma, Inc.

Export transactions ↓
Tapewire entity
8032
SEC CIK
0001130598
Parsed reports
252

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202610
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 13, 2024 Filed Mar 15, 2024 21:40 UTC Exercise / conversionRestricted Stock Units · Derivative 8,666 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008142 · form4-03152024_090303.xml · derivative · entry 3

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,334

Underlying: Common Stock · 8,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On March 13, 2023 the reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

F2 · derivative.expiration_date: On March 13, 2023 the reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 21:40 UTC Exercise / conversionCommon Stock 8,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-008142 · form4-03152024_090303.xml · nonDerivative · entry 1

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,567

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 22:38 UTC Exercise / conversionRestricted Stock Units · Derivative 6,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-003205 · form4-02092024_100205.xml · derivative · entry 3

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,900

Underlying: Common Stock · 6,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

F2 · derivative.expiration_date: On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 22:38 UTC Tax withholdingCommon Stock 2,443 $0.67 $1,636.81
Disclosure

SEC source: 0001415889-24-003205 · form4-02092024_100205.xml · nonDerivative · entry 2

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,901

Read SEC document
February 07, 2024 Filed Feb 9, 2024 22:38 UTC Exercise / conversionCommon Stock 6,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-003205 · form4-02092024_100205.xml · nonDerivative · entry 1

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 22:36 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Exercise / conversionRestricted Stock Units · Derivative 21,320 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-003204 · form4-02092024_100217.xml · derivative · entry 3

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,320

Underlying: Common Stock · 21,320 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

F2 · derivative.expiration_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 22:36 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Tax withholdingCommon Stock 9,212 $0.67 $6,172.04
Disclosure

SEC source: 0001415889-24-003204 · form4-02092024_100217.xml · nonDerivative · entry 2

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,408

Read SEC document
February 07, 2024 Filed Feb 9, 2024 22:36 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Exercise / conversionCommon Stock 21,320 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-003204 · form4-02092024_100217.xml · nonDerivative · entry 1

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,620

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
October 02, 2023 Filed Oct 27, 2023 20:41 UTC
Moyo Victor MCHIEF MEDICAL OFFICER
GrantStock Option (right to purchase) · Derivative 125,000 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001415889-23-014572 · form4-10272023_081005.xml · derivative · entry 1

Moyo Victor M · CIK 0001998323 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2033-10-02

F1 · derivative.exercise_date: These options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:49 UTC
Atadja PeterDirector
GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001415889-23-012231 · form4-08142023_090853.xml · derivative · entry 1

Atadja Peter · CIK 0001958563 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2033-08-10

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:52 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001415889-23-012232 · form4-08142023_090802.xml · derivative · entry 1

STOVER JACK E · CIK 0001203603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2033-08-10

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:53 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001415889-23-012234 · form4-08142023_090841.xml · derivative · entry 1

Shoemaker Mary Teresa · CIK 0001813552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2033-08-10

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:43 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001415889-23-012228 · form4-08142023_090819.xml · derivative · entry 1

GROOPMAN JEROME · CIK 0001218853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2033-08-10

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:47 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001415889-23-012230 · form4-08142023_090847.xml · derivative · entry 1

Clarke Trafford · CIK 0001958857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2033-08-10

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:45 UTC
MEHTA VIRENDirector
GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001415889-23-012229 · form4-08142023_090852.xml · derivative · entry 1

MEHTA VIREN · CIK 0001238969 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2033-08-10

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:41 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001415889-23-012227 · form4-08142023_090832.xml · derivative · entry 1

MARINO JAMES J · CIK 0001198578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2033-08-10

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:45 UTC Tax withholdingCommon Stock 1,422 $1.02 $1,450.44
Disclosure

SEC source: 0001415889-23-011867 · form4-08042023_080826.xml · nonDerivative · entry 2

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,444

Read SEC document
August 03, 2023 Filed Aug 4, 2023 20:42 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Tax withholdingCommon Stock 4,744 $1.01 $4,791.44
Disclosure

SEC source: 0001415889-23-011866 · form4-08042023_080842.xml · nonDerivative · entry 2

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,300

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:45 UTC Exercise / conversionRestricted Stock Units · Derivative 4,750 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-011867 · form4-08042023_080826.xml · derivative · entry 3

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,750

Underlying: Common Stock · 4,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.

F2 · derivative.expiration_date: On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:45 UTC Exercise / conversionCommon Stock 4,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-011867 · form4-08042023_080826.xml · nonDerivative · entry 1

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:42 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Exercise / conversionRestricted Stock Units · Derivative 12,567 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-011866 · form4-08042023_080842.xml · derivative · entry 3

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,567

Underlying: Common Stock · 12,567 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.

F2 · derivative.expiration_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:42 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Exercise / conversionCommon Stock 12,567 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-011866 · form4-08042023_080842.xml · nonDerivative · entry 1

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 12, 2023 Filed Jun 13, 2023 20:54 UTC Exercise / conversionRestricted Stock Units · Derivative 5,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-009750 · form4-06132023_080619.xml · derivative · entry 3

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 5,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

F2 · derivative.expiration_date: On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

Read SEC document
June 12, 2023 Filed Jun 13, 2023 20:54 UTC Tax withholdingCommon Stock 1,575 $1.14 $1,790.78
Disclosure

SEC source: 0001415889-23-009750 · form4-06132023_080619.xml · nonDerivative · entry 2

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,116

Read SEC document
June 12, 2023 Filed Jun 13, 2023 20:54 UTC Exercise / conversionCommon Stock 5,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-009750 · form4-06132023_080619.xml · nonDerivative · entry 1

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:19 UTC GrantRestricted Stock Units · Derivative 26,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004902 · form4-03142023_110331.xml · derivative · entry 2

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Common Stock · 26,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock.

F3 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary

F3 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:19 UTC GrantStock Option (right to purchase) · Derivative 79,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001415889-23-004902 · form4-03142023_110331.xml · derivative · entry 1

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,000

Underlying: Common Stock · 79,000 shares

Expires 2033-03-13

F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 22:48 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
GrantRestricted Stock Units · Derivative 69,333 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004866 · form4-03142023_100340.xml · derivative · entry 2

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,333

Underlying: Common Stock · 69,333 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock.

F3 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary

F3 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary

Read SEC document
March 13, 2023 Filed Mar 14, 2023 22:48 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
GrantStock Option (right to purchase) · Derivative 207,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001415889-23-004866 · form4-03142023_100340.xml · derivative · entry 1

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,000

Underlying: Common Stock · 207,000 shares

Expires 2033-03-13

F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 22:46 UTC
Gelder Mark S. MDCHIEF MEDICAL OFFICER
GrantRestricted Stock Units · Derivative 20,667 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004865 · form4-03142023_100352.xml · derivative · entry 2

Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,667

Underlying: Common Stock · 20,667 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock.

F3 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary

F3 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary

Read SEC document
March 13, 2023 Filed Mar 14, 2023 22:46 UTC
Gelder Mark S. MDCHIEF MEDICAL OFFICER
GrantStock Option (right to purchase) · Derivative 62,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001415889-23-004865 · form4-03142023_100352.xml · derivative · entry 1

Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,000

Underlying: Common Stock · 62,000 shares

Expires 2033-03-13

F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.

Read SEC document
February 07, 2023 Filed Feb 8, 2023 23:00 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Exercise / conversionRestricted Stock Units · Derivative 21,320 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-002171 · form4-02082023_110217.xml · derivative · entry 3

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,640

Underlying: Common Stock · 21,320 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

F2 · derivative.expiration_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

Read SEC document
February 07, 2023 Filed Feb 8, 2023 23:00 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Tax withholdingCommon Stock 6,977 $1.36 $9,488.72
Disclosure

SEC source: 0001415889-23-002171 · form4-02082023_110217.xml · nonDerivative · entry 2

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,477

Read SEC document
February 07, 2023 Filed Feb 8, 2023 23:00 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Exercise / conversionCommon Stock 21,320 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-002171 · form4-02082023_110217.xml · nonDerivative · entry 1

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 07, 2023 Filed Feb 8, 2023 22:58 UTC
Gelder Mark S. MDCHIEF MEDICAL OFFICER
Exercise / conversionRestricted Stock Units · Derivative 5,833 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-002168 · form4-02082023_100255.xml · derivative · entry 3

Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,667

Underlying: Common Stock · 5,833 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On February 7, 2022 the reporting person was granted 17,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

F2 · derivative.expiration_date: On February 7, 2022 the reporting person was granted 17,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

Read SEC document
February 07, 2023 Filed Feb 8, 2023 22:58 UTC
Gelder Mark S. MDCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 1,242 $1.36 $1,689.12
Disclosure

SEC source: 0001415889-23-002168 · form4-02082023_100255.xml · nonDerivative · entry 2

Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,487

Read SEC document
February 07, 2023 Filed Feb 8, 2023 22:58 UTC
Gelder Mark S. MDCHIEF MEDICAL OFFICER
Exercise / conversionCommon Stock 5,833 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-002168 · form4-02082023_100255.xml · nonDerivative · entry 1

Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 07, 2023 Filed Feb 8, 2023 22:56 UTC Exercise / conversionRestricted Stock Units · Derivative 6,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-002167 · form4-02082023_100254.xml · derivative · entry 3

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,800

Underlying: Common Stock · 6,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

F2 · derivative.expiration_date: On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.

Read SEC document
February 07, 2023 Filed Feb 8, 2023 22:56 UTC Tax withholdingCommon Stock 1,785 $1.36 $2,427.60
Disclosure

SEC source: 0001415889-23-002167 · form4-02082023_100254.xml · nonDerivative · entry 2

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,191

Read SEC document
February 07, 2023 Filed Feb 8, 2023 22:56 UTC Exercise / conversionCommon Stock 6,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-23-002167 · form4-02082023_100254.xml · nonDerivative · entry 1

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,976

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 23:59 UTC GrantStock Option (right to purchase) · Derivative 100,000 $0.00 Strike: $0.71 $0.00
Disclosure

SEC source: 0001415889-22-012768 · form4-12192022_111209.xml · derivative · entry 1

Clarke Trafford · CIK 0001958857 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-12-15

F1 · derivative.exercise_date: These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 23:56 UTC
Atadja PeterDirector
GrantStock Option (right to purchase) · Derivative 100,000 $0.00 Strike: $0.71 $0.00
Disclosure

SEC source: 0001415889-22-012767 · form4-12192022_111223.xml · derivative · entry 1

Atadja Peter · CIK 0001958563 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-12-15

F1 · derivative.exercise_date: These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary.

Read SEC document
August 18, 2022 Filed Aug 19, 2022 21:10 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0001415889-22-008914 · form4-08192022_050801.xml · derivative · entry 1

STOVER JACK E · CIK 0001203603 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2032-08-18

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 18, 2022 Filed Aug 19, 2022 20:59 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0001415889-22-008913 · form4-08192022_010813.xml · derivative · entry 1

MARINO JAMES J · CIK 0001198578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2032-08-18

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 18, 2022 Filed Aug 19, 2022 20:57 UTC
MEHTA VIRENDirector
GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0001415889-22-008912 · form4-08192022_010826.xml · derivative · entry 1

MEHTA VIREN · CIK 0001238969 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2032-08-18

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 18, 2022 Filed Aug 19, 2022 20:55 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0001415889-22-008911 · form4-08192022_010838.xml · derivative · entry 1

Shoemaker Mary Teresa · CIK 0001813552 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2032-08-18

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 18, 2022 Filed Aug 19, 2022 20:54 UTC GrantStock Option (right to purchase) · Derivative 66,468 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0001415889-22-008910 · form4-08192022_010815.xml · derivative · entry 1

GROOPMAN JEROME · CIK 0001218853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,468

Underlying: Common Stock · 66,468 shares

Expires 2032-08-18

F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date.

Read SEC document
August 03, 2022 Filed Aug 4, 2022 20:38 UTC Tax withholdingCommon Stock 1,355 $1.32 $1,788.60
Disclosure

SEC source: 0001415889-22-008261 · form4-08042022_010847.xml · nonDerivative · entry 2

Guerin Mark Patrick · CIK 0001607714 · CFO AND COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,076

Read SEC document
August 03, 2022 Filed Aug 4, 2022 20:34 UTC
Gelder Mark S. MDCHIEF MEDICAL OFFICER
Tax withholdingCommon Stock 1,135 $1.32 $1,498.20
Disclosure

SEC source: 0001415889-22-008260 · form4-08042022_010823.xml · nonDerivative · entry 2

Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,896

Read SEC document
August 03, 2022 Filed Aug 4, 2022 20:30 UTC
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
Tax withholdingCommon Stock 4,562 $1.32 $6,021.84
Disclosure

SEC source: 0001415889-22-008258 · form4-08042022_010852.xml · nonDerivative · entry 2

Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,134

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.